Is cycle network expansion cost-effective? A health economic evaluation of cycling in Oslo

BMC Public Health

Table 3 Cost and utility parameters

*Description of Costs and utilities*	*Cost ($) and utility values*	SD	*Distribution for sensitivity analysis*	*Source*
*Costs*
Investment cost, total/per capita	3,022,975/4.5	1.690	Gamma	[38]
Maintenance cost, total/per capita	44,438/0.066	0.020	Gamma	[12]
Cost of CHD 1st event	22,133	8300	Gamma	[19]
Cost of post-CHD 1st event	21,597	8099	Gamma	[19]
Cost of stroke 1st event	25,421	9533	Gamma	[19]
Cost of post stroke 1st event	11,962	4486	Gamma	[39]
Cost of T2D	5247	1968	Gamma	[40, 41]
Cost of cancer	13,810	5179	Gamma	[42]
*Utilities*
Healthy	1.00			Assumed
Cancer	0.74	0.015	Beta	[43]
CHD1	0.47	0.016	Beta	[28, 44]
CHD1+	0.56	0.016	Beta	[44]
Stroke1	0.50	0.036	Beta	[44]
Stroke1+	0.50	0.036	Beta	[44]
T2D	0.81	0.190	Beta	[45]
Wellbeing gain when active	0.05	0.013	Beta	[28]

ISSN: 1471-2458